Position in FTRE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,136,115
+$624,091 QoQ
Shares Held
65,294
+20.1% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#99
of 334 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $226,318,173 across 30 Biotechnology names. FTRE ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
368,978 | $105,147,660 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,845 | $32,950,970 | |
| 3 | INCY |
Incyte Corp
|
224,855 | $25,489,561 | |
| 4 | EXEL |
Exelixis, Inc.
|
437,138 | $23,784,676 | |
| 5 | INVA |
Innoviva, Inc.
|
274,391 | $6,231,419 | |
| 6 | TWST |
Twist Bioscience Corp
|
49,862 | $5,129,802 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
38,672 | $2,880,290 | |
| 8 | ASND |
Ascendis Pharma A/S
|
10,735 | $2,863,239 |
All Filings in FTRE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,136,115 | 65,294 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $512,024 | 54,355 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $473,909 | 27,473 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $228,796 | 27,173 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||